Co-stimulatory and cytokine-mediated interfaces between dendritic cells and CIK cells (DC-CIK interface)

The co-stimulatory and cytokine-mediated interfaces between dendritic cells (DCs) and cytokine-induced killer (CIK) cells represent a complex cellular interaction rather than a single molecular target. In this interface, DCs act as professional antigen-presenting cells that provide essential secondary signals to CIK cells—a heterogeneous population of CD3+CD56+ effector T cells with non-MHC-restricted cytolytic activity (Schmidt-Wolf et al., 1991; Marten et al., 2001). Key molecular components include co-stimulatory pairs such as CD80/CD86 on DCs interacting with CD28 on CIK cells, and the secretion of polarizing cytokines like IL-12 and IL-15 by DCs, which significantly boost CIK cell proliferation and IFN-gamma production (Zoll et al., 1998; Wang et al., 2014). This synergistic relationship is primarily exploited in adoptive immunotherapy (DC-CIK therapy) to treat various solid tumors and hematologic malignancies by enhancing the host's innate and adaptive anti-tumor immunity (Jakob et al., 2003). While the interface itself is a biological process, the individual receptors and cytokines involved are frequently targeted by drugs to modulate immune responses in oncology.

Other names

DC-CIK interactionDendritic cell-Cytokine-induced killer cell crosstalkDC-CIK co-cultureDC-CIK synapse

Enhancement of CIK cell cytotoxicity and proliferation through DC-mediated antigen presentation, co-stimulatory signaling (e.g., CD80/CD86-CD28), and paracrine cytokine secretion.